NHIA welcomes Brightree to Future of Infusion Advisory Council

The FIAC is a strategic advisory group to NHIA comprised of manufacturing and service companies who are deeply invested in the home and specialty infusion industry. The group consistently works with the association staff and Board of Directors to address critical issues, challenges, and opportunities facing this growing community. Current FIAC members include; 3M Health Care, Baxter Healthcare Corporation, B. Braun Medical Inc., Integrated Medical Systems, Managed Health Care Associates, Inc., McKesson, Moog Medical Devices Group, Merck & Co. Inc, Innovatix, LLC, Pfizer Alternate Site, Provista, WellSky, Smiths Medical, Janssen Biotech, Inc., and now Brightree.

Brightree is a health care information technology company that develops cloud-based platform solutions for home infusion and other post-acute healthcare providers to support better outcomes for patients. The Brightree Business Management Software helps home care pharmacies fill and bill more efficiently, reduce errors and improve satisfaction for staff, referral sources and patients.

“Home infusion is a complex business, requiring fluid coordination between a number of key stakeholders and accordance with strict regulations,” said Rob Boeye, Brightree’s executive vice president. “We’re a proud supporter of the industry, both through our pharmacy software suite, which acts as a single solution for automating all clinical, billing and reporting needs, and our ongoing partnership with NHIA. We’re proud to join our peers as members of FIAC so we can continue to support home and specialty infusion pharmacies in further optimizing their business processes, meeting regulatory requirements with ease and enabling the highest possible quality of patient care.”

“We’re excited to welcome Brightree to the FIAC and look forward to their partnership with the association in advancing initiatives that promote the value of home and specialty infusion services,” said NHIA President & CEO Connie Sullivan, BSPharm.

“Brightree’s software offers home infusion providers important functionality to reduce the complexities and costs associated with managing compounded and non-compounded medications, equipment and supplies. Home infusion software will be integral to the future growth and advancement of our industry, and we look forward to their participation in the FIAC,” said NHIA Board Chair Logan Davis, PharmD.

NHIA is a trade association that represents companies that provide infusion therapy to patients in their homes, as well as companies that manufacture and supply infusion and specialty pharmacy products. Infusion therapy involves patient-specific compounded medications, supplies, and a range of pharmacy, nursing, and other clinical services for delivering care to patients in the home setting. For more information, visit www.nhia.org.

Brightree LLC enables out-of-hospital care organizations to improve their business performance and deliver better health outcomes. As an industry-leading cloud-based healthcare IT company, Brightree provides solutions and services for thousands of organizations in home medical equipment, pharmacy, home infusion and orthotic and prosthetic. Brightree is a wholly owned subsidiary of ResMed (NYSE: RMD, ASX: RMD). To learn more, visit brightree.com and follow @Brightree on Twitter.

###

About Brightree 
Brightree enables out-of-hospital care organizations to improve their business performance and deliver better health outcomes. As an industry-leading cloud-based healthcare IT company, Brightree provides solutions and services for thousands of organizations in home medical equipment and pharmacy, home health, hospice and home infusion. Brightree is a wholly owned subsidiary of ResMed (NYSE: RMD, ASX: RMD). To learn more, visit www.brightree.com and follow @Brightree on Twitter.